BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27713330)

  • 1. Role of Leukotrienes and Leukotriene Modifiers in Asthma.
    Montuschi P
    Pharmaceuticals (Basel); 2010 Jun; 3(6):1792-1811. PubMed ID: 27713330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene modifiers for asthma treatment.
    Montuschi P; Peters-Golden ML
    Clin Exp Allergy; 2010 Dec; 40(12):1732-41. PubMed ID: 21059119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological modulation of the leukotriene pathway in allergic airway disease.
    Montuschi P; Sala A; Dahlén SE; Folco G
    Drug Discov Today; 2007 May; 12(9-10):404-12. PubMed ID: 17467577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on leukotrienes and their receptors with reference to asthma.
    Singh RK; Tandon R; Dastidar SG; Ray A
    J Asthma; 2013 Nov; 50(9):922-31. PubMed ID: 23859232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotrienes, antileukotrienes and asthma.
    Montuschi P
    Mini Rev Med Chem; 2008 Jun; 8(7):647-56. PubMed ID: 18537720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.
    Holgate ST; Peters-Golden M; Panettieri RA; Henderson WR
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S18-34; discussion S34-6. PubMed ID: 12532084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding roles for leukotrienes in airway inflammation.
    Peters-Golden M
    Curr Allergy Asthma Rep; 2008 Jul; 8(4):367-73. PubMed ID: 18606091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileukotriene agents for the treatment of lung disease.
    Scott JP; Peters-Golden M
    Am J Respir Crit Care Med; 2013 Sep; 188(5):538-44. PubMed ID: 23822826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotrienes and airway inflammation.
    Okunishi K; Peters-Golden M
    Biochim Biophys Acta; 2011 Nov; 1810(11):1096-102. PubMed ID: 21352897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1.
    Parmentier CN; Fuerst E; McDonald J; Bowen H; Lee TH; Pease JE; Woszczek G; Cousins DJ
    J Allergy Clin Immunol; 2012 Apr; 129(4):1136-42. PubMed ID: 22391114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukotriene modifiers].
    Minoguchi K; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
    Sharma JN; Mohammed LA
    Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
    Leff AR
    Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene modifiers in pediatric asthma management.
    Bisgaard H
    Pediatrics; 2001 Feb; 107(2):381-90. PubMed ID: 11158473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotrienes as mediators of asthma.
    Nicosia S; Capra V; Rovati GE
    Pulm Pharmacol Ther; 2001; 14(1):3-19. PubMed ID: 11162414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotrienes and isocyanate-induced asthma: a pilot study.
    Lemiere C; Pelissier S; Tremblay C; Chaboillez S; Thivierge M; Stankova J; Rola-Pleszczynski M
    Clin Exp Allergy; 2004 Nov; 34(11):1684-9. PubMed ID: 15544591
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.